Dr. Cirocco strives to provide cutting edge techniques for disorders and diseases specific to the colon, rectum and anus with a special emphasis on advanced surgical approaches to avoid a permanent colostomy for patients with Inflammatory Bowel Disease such as Chronic Ulcerative Colitis (CUC) and Familial Adenomatous Polyposis (FAP) including ileal pouch-anal anastomoses (IPAA) and coloanal anastomoses for patients with very low rectal cancers. Furthermore, he has published in-depth outcomes of a personal series of colorectal surgical procedures for rectal cancer and rectal prolapse in the hopes of improving the care of these patients via publications in respected journals and influence via regional (Central, Western and Midwest Surgical Associations) and national surgical societies (American Society of Colon and Rectal Surgeons, American College of Surgeons) and the American Board of Colon and Rectal Surgery (Senior Examiner/Associate Member of the Written Examination Committee).
Dr. Cirocco is Professor of Surgery and Program Director of the Colorectal Surgery Residency Training Program at The Ohio State University College of Medicine with privileges at University Hospital and The James Cancer Hospital (OSU Wexner Medical Center). He started his career in academia in New York City at the State University of New York - Health Sciences Center at Brooklyn (SUNY-Downstate Medical Center) in New York City where he was involved in early attempts at preoperative staging of rectal cancer using transrectal ultrasound as part of a multidisciplinary approach that included preoperative (neoadjuvant) chemoradiotherapy. This multidisciplinary neoadjuvant approach to rectal cancer has been the biggest advance in the management of rectal cancer in the past 25 years and combined with advanced surgical techniques has resulted in improved outcomes of rectal cancer resection such as lower rates of recurrence, increased rates of sphincter preservation and even improvement in long-term survival. Dr. Cirocco took these advances back to the Midwest to Kansas City and has gone on to publish a personal series of patients in a non-academic community hospital setting with outcomes comparable to published results from tertiary care centers and multi-institutional trials (e.g. ACOSOG Z6051). He has returned to an academic setting at OSU, joining the Division of Colon & Rectal Surgery to initiate and become program director of an ACGME-accredited colorectal surgery residency training program which began January 15, 2016.